Molecular Biomedicine (ISSN 2662-8651) is an open-access journal published by Springer Nature in Switzerland. It covers Biochemistry, Genetics and Molecular Biology, Molecular Biology and Molecular Medicine. It is indexed in Scopus, Web of Science, PubMed, DOAJ and HEC. Recorded metrics: impact factor 13, Scopus Q1, Web of Science Q1, CiteScore 11.7 and HEC X-Category. Article processing charge: USD 2,690. This profile brings together the journal's ISSN, publisher, country, subject area, HEC category, Scopus data, SJR and SCImago rank, Web of Science data, impact factor, indexing, open access status, APC, waiver policy, time to publication, aims and scope, about the journal, author instructions, journal website and registration details from the most reputable indexes, in one place.
Molecular Biomedicine
Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.
Journal lists: Q1 journals · HEC X category journals · Scopus journals · Web of Science journals · PubMed journals · DOAJ journals · SCImago journals · ESCI journals · Impact factor journals · Open access journals · Scopus Q1 journals · Web of Science Q1 journals · Open access Q1 journals · Fast publication Q1 journals · Q1 Biochemistry journals · Q1 Genetics and Molecular Biology journals
Quick answers about Molecular Biomedicine
Is Molecular Biomedicine HEC recognised?
Yes. The catalogue records Molecular Biomedicine in HEC category X of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.
Is Molecular Biomedicine indexed in Scopus?
Yes. Molecular Biomedicine is listed as Scopus-indexed, in quartile Q1, with a CiteScore of 11.7. Check its current status on the Scopus Sources page.
Is Molecular Biomedicine in Web of Science?
Yes. Molecular Biomedicine is listed as a Web of Science journal in the Emerging Sources Citation Index (ESCI), with Web of Science quartile Q1. Confirm on Clarivate's Master Journal List.
What is the impact factor of Molecular Biomedicine?
The recorded journal impact factor of Molecular Biomedicine is 13. Clarivate updates impact factors every year in Journal Citation Reports.
Is Molecular Biomedicine open access, and what does it charge?
Molecular Biomedicine is an open-access journal and its APC is USD 2,690. Fees change, so check the journal's website before you submit.
How long does Molecular Biomedicine take to publish?
The recorded average time from submission to publication is about 10 weeks. Individual papers can take longer, especially when revisions are requested.
Who publishes Molecular Biomedicine?
Molecular Biomedicine is published by Springer Nature in Switzerland, under ISSN 2662-8651.
Research profile
- 635articles indexed
- 14,077citations
- 61h-index
- 13.162-year mean citedness
- 1998first year indexed
Main research topics: Cancer Immunotherapy and Biomarkers, SARS-CoV-2 and COVID-19 Research, Epigenetics and DNA Methylation, Immunotherapy and Immune Responses, Cancer Cells and Metastasis, Cancer-related molecular mechanisms research.
Source: OpenAlex (CC0), retrieved 21 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.
Browse similar journals
- Biochemistry journals (2,272)
- Genetics and Molecular Biology journals (2,274)
- Molecular Biology journals (429)
- Journals indexed in Scopus (31,185)
- Journals indexed in Web of Science (22,643)
- Journals indexed in PubMed (16,086)
- Journals indexed in DOAJ (10,243)
- Journals indexed in HEC (34,823)
- Scopus Q1 journals (9,924)
- Web of Science Q1 journals (4,519)
- HEC X-Category journals (9,306)
- Journals published in Switzerland (1,150)
- Springer Nature journals (2,655)